Cerity Partners OCIO’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,515
Closed -$124K 425
2022
Q2
$124K Hold
10,515
﹤0.01% 411
2022
Q1
$200K Hold
10,515
0.01% 409
2021
Q4
$279K Sell
10,515
-89
-0.8% -$3.06K 0.01% 369
2021
Q3
$436K Sell
10,604
-16
-0.2% -$877 0.01% 319
2021
Q2
$602K Hold
10,620
0.02% 282
2021
Q1
$446K Buy
10,620
+3,855
+57% +$220K 0.02% 294
2020
Q4
$474K Sell
6,765
-3,750
-36% -$154K 0.02% 262
2020
Q3
$295K Buy
+10,515
New +$342K 0.01% 293

Other funds holding EDIT

Cerity Partners OCIO's EDIT Position: Q3 2022 in Review

Cerity Partners OCIO sold out of Editas Medicine (EDIT) in Q3 2022, closing a stake of 10,515 shares — an estimated $124K sold.

Cerity Partners OCIO first reported a position in EDIT in Q3 2020 and held it in 8 quarters. The position peaked at $602K in Q2 2021. 264 funds tracked by Wall St. Rank hold EDIT as of Q3 2022.

  • Cerity Partners OCIO reported no remaining Editas Medicine position as of Q3 2022 after selling out during the quarter.
  • Cerity Partners OCIO sold 10,515 Editas Medicine shares in Q3 2022, an estimated $124K.
  • Cerity Partners OCIO first reported a position in Editas Medicine in Q3 2020 and held it in 8 quarters.
  • Cerity Partners OCIO's Editas Medicine position peaked at $602K in Q2 2021.
  • 264 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2022.

Based on Cerity Partners OCIO's 13F filing for Q3 2022, filed 20 Oct 2022.